Combined Bupivacaine and Exparel for Postoperative Pain
(LAVA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to compare recovery unit and post operation day (POD) 1 pain score in women following elective robotic assisted TLH (RA-TLH) for benign indication with and without local vaginal cuff injection of short acting bupivacaine and long acting Exparel, to evaluate postoperative pain management and control by assessing the amount and frequency of NSAIDS and opioids taken and to assess bleeding, vaginal discharge and or vaginal dehiscence at the postoperative follow up visit.
Who Is on the Research Team?
Asha B Bhalwal, MD
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for women having a planned robotic-assisted total laparoscopic hysterectomy (removal of the uterus) for non-cancerous reasons. Participants must be eligible for this surgery and able to follow study instructions.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- Combined Bupivacaine and Exparel
Trial Overview
The study compares pain control after surgery between two groups: one receives a local injection of both short-acting bupivacaine and long-acting Exparel at the surgical site, while the other gets a saline injection as a placebo.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.